INTERNATIONAL STEM CELL CORPORATION (ISCO) Net margin 2016–2025
INTERNATIONAL STEM CELL CORPORATION (ISCO) net profit margin by fiscal year — reported net income divided by reported revenue.
-4.6%FY2025 · since FY2016: -15.1% → -4.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4.6% | -2.3 pp |
| FY2024 | -2.3% | -0.6 pp |
| FY2023 | -1.7% | +2.4 pp |
| FY2022 | -4.0% | +8.5 pp |
| FY2021 | -12.5% | +25.7 pp |
| FY2020 | -38.2% | +6.8 pp |
| FY2019 | -45.0% | -25.8 pp |
| FY2018 | -19.2% | +62.2 pp |
| FY2017 | -81.4% | -66.3 pp |
| FY2016 | -15.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ISCO financial trends
ISCO RevenueISCO Net incomeISCO Gross profitISCO Gross marginISCO Operating incomeISCO Operating marginISCO Operating cash flowISCO Free cash flowISCO Capital expendituresISCO Return on equityISCO Stock buybacksISCO Dividends paidISCO Total assetsISCO Total liabilitiesISCO Shareholders’ equityISCO overview →